A β42 treatment of the brain side reduced the level of flotillin from endothelial cells on the blood side via FGF-2 signaling in a blood–brain barrier model

Our previous study showed that the flotillin level is decreased in the blood of patients with Alzheimer ’s disease (AD) when compared to that of patients with non-AD and vascular dementia; however, the molecula...

Source: Molecular Brain - January 26, 2023 Category: Neuroscience Authors: Tomohisa Nakamura, Tadahiro Hashita, Yuxin Chen, Yuan Gao, Yang Sun, Sadequl Islam, Hiroyuki Sato, Yasuyuki Shibuya, Kun Zou, Tamihide Matsunaga and Makoto Michikawa Tags: Research Source Type: research